Guyi Wang
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in ⓘ
-
- COVID-19 Clinical Research Studies 11
-
- Long-Term Effects of COVID-19 7
- Co-authors
- Chenfang Wu (13 shared papers)Guobao Wu (11 shared papers)Yanjun Zhong (10 shared papers)Bo Yu (9 shared papers)Siye Zhang (8 shared papers)Quan Zhang (6 shared papers)Jianlei Lv (6 shared papers)Fang Wu (6 shared papers)
- Journals
- Frontiers in Public Health (2 papers)Frontiers in Medicine (2 papers)Frontiers in Pharmacology (2 papers)Scientific Reports (1 paper)Fractals (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Guyi Wang
31 papers receiving 711 citations
Peers
Comparison fields: 5 of 100
- Infectious Diseases 399
- Critical Care and Intensive Care Medicine 67
- Neurology 167
- Endocrinology, Diabetes and Metabolism 89
- Epidemiology 152
Countries citing papers authored by Guyi Wang
This map shows the geographic impact of Guyi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guyi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guyi Wang more than expected).
Fields of papers citing papers by Guyi Wang
This network shows the impact of papers produced by Guyi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guyi Wang. The network helps show where Guyi Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Guyi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 163 | |
| 2 | 2020 | 113 | |
| 3 | 2020 | 87 | |
| 4 | 2016 | 41 | |
| 5 | 2022 | 31 | |
| 6 | 2013 | 30 | |
| 7 | 2013 | 29 | |
| 8 | 2023 | 21 | |
| 9 | 2020 | 20 | |
| 10 | 2021 | 19 | |
| 11 | 2021 | 18 | |
| 12 | 2021 | 16 | |
| 13 | 2020 | 15 | |
| 14 | 2011 | 15 | |
| 15 | 2021 | 14 | |
| 16 | 2013 | 13 | |
| 17 | Effects of beta-arrestin 2 on cytokine production of CD4+ T lymphocytes of mice with allergic asthma. | 2011 | 12 |
| 18 | Effects and mechanism of arsenic trioxide on reversing the asthma pathologies including Th17-IL-17 axis in a mouse model. | 2012 | 11 |
| 19 | A PREGNANT WOMAN WITH AVIAN INFLUENZA A (H7N9) VIRUS PNEUMONIA AND ARDS MANAGED WITH EXTRACORPOREAL MEMBRANE OXYGENATION. | 2015 | 10 |
| 20 | 2020 | 9 |
About Guyi Wang
Guyi Wang is a scholar working on Infectious Diseases, Neurology, Dermatology, Music and Behavioral Neuroscience, having authored 32 papers that have together received 732 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (11 papers), Long-Term Effects of COVID-19 (7 papers), Asthma and respiratory diseases (4 papers), Respiratory Support and Mechanisms (3 papers), Dermatological and COVID-19 studies (3 papers), Music Therapy and Health (3 papers), Pancreatitis Pathology and Treatment (2 papers) and Neuroscience and Music Perception (2 papers). The work is most often cited by research in Infectious Diseases (399 citations), Critical Care and Intensive Care Medicine (67 citations), Neurology (167 citations), Endocrinology, Diabetes and Metabolism (89 citations) and Epidemiology (152 citations). Guyi Wang has collaborated with scholars based in China and United States. Frequent co-authors include Chenfang Wu, Guobao Wu, Yanjun Zhong, Bo Yu, Siye Zhang, Quan Zhang, Jianlei Lv, Fang Wu, Haiyun Dong and Shangjie Wu. Their work appears in journals such as Frontiers in Public Health, Frontiers in Medicine, Frontiers in Pharmacology, Scientific Reports and Fractals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.